1. Advanced Glycation End Products Accelerate Ischemia/Reperfusion Injury Through Receptor of Advanced End Product/Nitrative Thioredoxin Inactivation in Cardiac Microvascular Endothelial Cells
- Author
-
Wayne Bond Lau, Chenhai Xia, Lu Yang, Ronghua Luan, Lu Sun, Rutao Wang, Ling Tao, Haichang Wang, Kun Lian, Yanzhuo Ma, Rong-qing Zhang, and Yi Liu
- Subjects
Glycation End Products, Advanced ,Male ,Physiology ,Primary Cell Culture ,Receptor for Advanced Glycation End Products ,Clinical Biochemistry ,Population ,Myocardial Ischemia ,Ischemia ,Myocardial Reperfusion Injury ,Pharmacology ,Nitric Oxide ,medicine.disease_cause ,Biochemistry ,Nitric oxide ,chemistry.chemical_compound ,Thioredoxins ,Superoxides ,Glycation ,Animals ,Medicine ,Rats, Wistar ,Receptors, Immunologic ,education ,Molecular Biology ,Cells, Cultured ,General Environmental Science ,education.field_of_study ,Nitrates ,L-Lactate Dehydrogenase ,biology ,business.industry ,Endothelial Cells ,Serum Albumin, Bovine ,Cell Biology ,medicine.disease ,Cell Hypoxia ,Rats ,Nitric oxide synthase ,Oxidative Stress ,chemistry ,Microvessels ,biology.protein ,General Earth and Planetary Sciences ,business ,Reperfusion injury ,Peroxynitrite ,Oxidative stress - Abstract
The advanced glycation end products (AGEs) are associated with increased cardiac endothelial injury. However, no causative link has been established between increased AGEs and enhanced endothelial injury after ischemia/reperfusion. More importantly, the molecular mechanisms by which AGEs may increase endothelial injury remain unknown. Adult rat cardiac microvascular endothelial cells (CMECs) were isolated and incubated with AGE-modified bovine serum albumin (BSA) or BSA. After AGE-BSA or BSA preculture, CMECs were subjected to simulated ischemia (SI)/reperfusion (R). AGE-BSA increased SI/R injury as evidenced by enhanced lactate dehydrogenase release and caspase-3 activity. Moreover, AGE-BSA significantly increased SI/R-induced oxidative/nitrative stress in CMECs (as measured by increased inducible nitric oxide synthase expression, total nitric oxide production, superoxide generation, and peroxynitrite formation) and increased SI/R-induced nitrative inactivation of thioredoxin-1 (Trx-1), an essential cytoprotective molecule. Supplementation of EUK134 (peroxynitrite decomposition catalyst), human Trx-1, or soluble receptor of advanced end product (sRAGE) (a RAGE decoy) in AGE-BSA precultured cells attenuated SI/R-induced oxidative/nitrative stress, reduced SI/R-induced Trx-1 nitration, preserved Trx-1 activity, and reduced SI/R injury. Our results demonstrated that AGEs may increase SI/R-induced endothelial injury by increasing oxidative/nitrative injury and subsequent nitrative inactivation of Trx-1. Interventions blocking RAGE signaling or restoring Trx activity may be novel therapies to mitigate endothelial ischemia/reperfusion injury in the diabetic population.
- Published
- 2011